A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/70 (2006.01) A61K 39/00 (2006.01) C07H 15/04 (2006.01) C07H 15/10 (2006.01)
Patent
CA 2316041
The use of glycolipids, in particular galactosylceramide, glucosylceramide and lactosylceramide, and specific catchers therefor (antibodies or lectins), in particular monoclonal antibodies, for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual and for use in the production of pharmaceutical preparations for treatment of said conditions is disclosed.
L'invention concerne l'utilisation de glycolipides, notamment de glactosylcéramide, glucosylcéramide, et lactosylcéramide, et leurs agents de fixation (anticorps ou lectines), notamment les anticorps monoclonaux, en vue de prévenir ou de traiter les prédiabètes, diabètes et/ou complications associées d'un patient et de produire des préparations pharmaceutiques destinées au traitement des états mentionnés.
Buschard Karsten
Fredman Pam
A+ Science Invest Ab
Fetherstonhaugh & Co.
LandOfFree
Galactosylceramide, glucosylceramide, lactosylceramide, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galactosylceramide, glucosylceramide, lactosylceramide, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galactosylceramide, glucosylceramide, lactosylceramide, and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1528932